CN1256140C - Chinese medicne for treating liver cancer - Google Patents
Chinese medicne for treating liver cancer Download PDFInfo
- Publication number
- CN1256140C CN1256140C CN 200310125109 CN200310125109A CN1256140C CN 1256140 C CN1256140 C CN 1256140C CN 200310125109 CN200310125109 CN 200310125109 CN 200310125109 A CN200310125109 A CN 200310125109A CN 1256140 C CN1256140 C CN 1256140C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- fructus
- liver cancer
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a traditional Chinese medicine for treating liver cancer, which belongs to the technical field of a traditional Chinese medicine product. The traditional Chinese medicine is prepared from the components with the following parts by weight: 1.0 to 2.0 of laggera alataschul, 1.0 to 2.0 of spiny amarauth herb, 0.8 to 1.6 of red peony root, 0.8 to 1.6 of curcuma root, 0.8 to 1.6 of orange fruit, 0.8 to 1.6 of phellodendron, 0.8 to 1.6 of cape jasmine fruit, 0.6 to 1.2 of herba agastachis, 0.6 to 1.2 of giant knotweed rhizome, 0.6 to 1.2 of stephania sinica, 0.6 to 1.2 of hawthorn, 0.5 to 1.0 of peach seed and 0.3 to 0.5 of safflower which are ground and mixed. Compared with the prior art, the traditional Chinese medicine recovers and improves the functions of a human body to treat cancers by improving the imbalance of yin and yang, the stagnation of qi and blood, the phlegm dampness and the collateral resistance of the human body, and has the characteristics of high minification for treating focuses, high therapy effective rate and high cure rate.
Description
Technical field
The present invention relates to the Chinese medicine field of pharmaceutical technology, especially a kind of Chinese medicine that is used for the treatment of hepatocarcinoma.
Background technology
The existing cancer Chinese medicine of controlling is especially treated the Chinese medicine of hepatocarcinoma, and the patient uses a focus minification, effective percentage, cure rate all undesirable, after the small number of patients medication untoward reaction is arranged.I think that through the extensively a large amount of clinical practices checkings of three more than ten years one of its reason is because people have neglected the reversible of cancer, and medication still definite inadequately due to.
Summary of the invention
The invention provides a kind of Chinese medicine for the treatment of hepatocarcinoma, it can be by improving human body imbalance of YIN and YANG, coagulation of QI-blood, phlegm-damp resistance network reason, recovers and improve function of human body and treat cancer, thereby improve focus minification, treatment effective percentage and cure rate.
For achieving the above object, the included medicine material and the parts by weight thereof of Chinese medicine of the treatment hepatocarcinoma of the present invention's employing are: Laggera alata (Roxb.) Sch.-Bip. 1.0～1.5, Amaranthus spinosus L. 1.0～1.5, Radix Paeoniae Rubra 0.8～1.2, Radix Curcumae 0.8～1.2, Fructus Aurantii 0.8～1.2, Cortex Phellodendri 0.8～1.2, Fructus Gardeniae 0.8～1.2, Herba Pogostemonis 0.6～1.0, Rhizoma Polygoni Cuspidati 0.6～1.0, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) 0.6～1.0, Fructus Crataegi 0.6～1.0, Semen Persicae 0.5～1.0, Flos Carthami 0.3～0.5.The Chinese medicine of this treatment hepatocarcinoma be with the above-mentioned medicine of respectively distinguishing the flavor of mix be crushed into that powder forms or according to the above ratio each component pulverize separately become powder after mix homogeneously form.
Laggera alata (Roxb.) Sch.-Bip. in the above-mentioned prescription, Rhizoma Polygoni Cuspidati, Amaranthus spinosus L. play adjusts forcefully that existing negative and positive in the body are partially, the effect of heat clearing away eliminating dampness by diuresis; Herba Pogostemonis plays the turbid removing dampness of fragrant addiction; Semen Persicae, Flos Carthami, Radix Paeoniae Rubra play that circulation of qi promoting is invigorated blood circulation, suitable promoting blood circulation, and they constitute the main component of this medicine jointly.Cortex Phellodendri in the above-mentioned prescription plays the kind asthenic fire of putting out; Fructus Gardeniae plays kind clearing away liver-fire; Fructus Crataegi plays kind eliminating indigested food; Radix Curcumae, Fructus Aurantii work to strengthen dispersing the stagnated live-QI to relieve the stagnation of QI, promoting qi circulation, resolving food retention; Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) plays anti-inflammatory analgetic and antidotal effect.
Above-mentioned medicine can directly be made powder and use, and also can be loaded on the former use of glue, can also make tablet and use.
Owing to adopted such scheme the present invention compared with prior art to have following beneficial effect:
Respectively distinguish the flavor of among the present invention combination of medicine can make this medical instrument have circulation of qi promoting to dredge strongly fragrant, blood circulation promoting and blood stasis dispelling, turbid, the anticancer antiviral of damp eliminating addiction, scattered inflammatory swelling, press down the convulsion pain relieving, hold back the effect that skin ulcer relieves internal heat, among late period, early stage liver cancer patient the reverse curative effect is arranged.As follows to 20 routine advanced liver cancer patient treatments:
Symptom and sign change before and after the table 1:20 example advanced liver cancer patient treatment
| Symptom and sign | The example number | Cure | Obviously alleviate | The slight alleviation | Do not have and alleviate | Remission rate (%) |
| The low grade fever | 6 | 2 | 4 | 0 | 0 | 100 |
| The middle burning | 3 | 1 | 0 | 1 | 1 | 66.7 |
| Hyperpyrexia | 8 | 1 | 0 | 3 | 4 | 50 |
| The cancer heating | 19 | 4 | 10 | 0 | 5 | 73.7 |
| Body temperature is on the low side | 3 | 0 | 0 | 1 | 2 | 33.3 |
| Distending pain | 20 | 4 | 6 | 3 | 7 | 65 |
| Abdominal muscle is tightly hard | 11 | 3 | 5 | 3 | 0 | 100 |
| Greasy anorexia | 20 | 3 | 5 | 5 | 7 | 65 |
| Feel sick | 16 | 2 | 3 | 4 | 7 | 56.3 |
| Vomiting | 5 | 1 | 1 | 0 | 3 | 40 |
| It is weak to become thin | 20 | 4 | 3 | 6 | 7 | 65 |
| Ascites | 9 | 1 | 5 | 2 | 1 | 88.9 |
| Jaundice | 2 | 0 | 0 | 0 | 2 | 0 |
Focus is dwindled situation before and after the table 2:20 example advanced liver cancer patient treatment
| Lesion type | The example number | Focus is dwindled | ||||
| The 15-20 millimeter | The 10-15 millimeter | The 5-10 millimeter | No change | Minification (%) | ||
| Massive type | 7 | 2 | 3 | 0 | 2 | 71.4 |
| The huge sudden and violent elongated of the liver of occurring together | 1 | 1 | 0 | 0 | 0 | 100 |
| Infiltrative type | 1 | 0 | 0 | 0 | 0 | 100 |
| Distribute nodular type | 8 | 0 | 0 | 6 | 2 | 75 |
| Distribute tuberosity companion atherosclerotic type | 3 | 0 | 0 | 0 | 3 | 0 |
| Add up to | 20 | 3 | 3 | 6 | 7 | 60 |
4 examples of clinical cure among the above-mentioned 20 routine patients except that 1 people was recurred after a year and a half, are gone through behind all the other 3 routine clinical cures and were not had recurrence in 8 years.
The specific embodiment
Make the embodiment of the Chinese medicine of 13.5 kilograms of this treatment hepatocarcinoma:
A, take by weighing following each medicine material: 1.5 kilograms of Laggera alata (Roxb.) Sch.-Bip., 1.5 kilograms of Amaranthus spinosus L.s, 1.2 kilograms of Radix Paeoniae Rubra, 1.2 kilograms of Radix Curcumaes, 1.2 kilograms of Fructus Aurantiis, 1.2 kilograms of Cortex Phellodendris, 1.2 kilograms of Fructus Gardeniaes, 0.9 kilogram of Herba Pogostemonis, 0.9 kilogram of Rhizoma Polygoni Cuspidati, 0.9 kilogram of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae), 0.9 kilogram of Fructus Crataegi, 0.6 kilogram in Semen Persicae, 0.3 kilogram on Flos Carthami.
B, above-mentioned each medicine material is mixed the back pulverize, cross 100 mesh sieves and form.
This use of loosing is age-based, body weight, physical strength are determined consumption, and when being used for the treatment of, day clothes three times were taken once in preferably per 7 hours, each dose, and adult 10-12.9 gram juvenilely reduces by half by adult human amount, and child 2.9-4.3 restrains.Diet white sugar, remelt sugar, glucide, monosodium glutamate and chicken, duck, fish, goose and eggs thereof in the medication period; Animal livers, Fructus Litchi, Fructus Ananadis comosi, Fructus Mangifera Indicae, Fructus Musae, chest nut, Arillus Longan, der Kohlrabi, cabbage mustard bag, cabbage mustard bud, cabbage mustard flower, Fructus Solani melongenae, bamboo sprout, Fructus Cucurbitae moschatae, Fructus Cucurbitae moschatae flower seedling, mushroom class, Fructus Colocasiae Esculentae class, Radix Raphani, water spinach, curing food.Avoiding Chinese and western medicine mixes and to control and exhaustion due to sexual indulgence rage, the too quickly behavior of exerting oneself.
This medicine can be loaded in the capsule and take.Also can be added with other flavor Chinese medicine according to the state of an illness share.
Claims (1)
1, a kind of Chinese medicine for the treatment of hepatocarcinoma, its medicine material and parts by weight thereof are: Laggera alata (Roxb.) Sch.-Bip. 1.0～2.0, Amaranthus spinosus L. 1.0～2.0, Radix Paeoniae Rubra 0.8～1.6, Radix Curcumae 0.8～1.6, Fructus Aurantii 0.8～1.6, Cortex Phellodendri 0.8～1.6, Fructus Gardeniae 0.8～1.6, Herba Pogostemonis 0.6～1.2, Rhizoma Polygoni Cuspidati 0.6～1.2, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) 0.6～1.2, Fructus Crataegi 0.6～1.2, Semen Persicae 0.5～1.0, Flos Carthami 0.3～0.5; The above-mentioned medicated powder of respectively distinguishing the flavor of is broken, mix.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310125109 CN1256140C (en) | 2003-12-27 | 2003-12-27 | Chinese medicne for treating liver cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310125109 CN1256140C (en) | 2003-12-27 | 2003-12-27 | Chinese medicne for treating liver cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1554430A CN1554430A (en) | 2004-12-15 |
| CN1256140C true CN1256140C (en) | 2006-05-17 |
Family
ID=34338996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200310125109 Expired - Fee Related CN1256140C (en) | 2003-12-27 | 2003-12-27 | Chinese medicne for treating liver cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1256140C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1989989B (en) * | 2005-12-26 | 2010-07-14 | 浙江海正药业股份有限公司 | Use of laggera plant abstract in inhibiting herpes simplex virus and hepatitis B virus |
| CN101843820B (en) * | 2010-05-11 | 2011-08-31 | 李国� | Glucuronolactone-containing medicament for protecting liver and lowering transaminase |
-
2003
- 2003-12-27 CN CN 200310125109 patent/CN1256140C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1554430A (en) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101524464B (en) | Pure traditional Chinese medicine composition for treating female breast diseases and pure traditional Chinese medicine preparation prepared thereby | |
| CN102210847A (en) | Method for preparing medicinal composition capsules for treating dysmenorrheal and application thereof | |
| CN102772737B (en) | Traditional Chinese medicine composition for treating liver cirrhosis and fibrosis and preparation method thereof | |
| CN101249243B (en) | Chinese medicine for curing acute leukemia | |
| CN104147536B (en) | A kind of pharmaceutical composition treating hemorrhoid and preparation method thereof | |
| CN103055193A (en) | Chinese medicinal composition for treating eczema | |
| CN100409870C (en) | Chinese traditional medicinal composition for treating psoriasis | |
| CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
| CN1256140C (en) | Chinese medicne for treating liver cancer | |
| CN101816745B (en) | Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof | |
| CN115040612A (en) | Composition for regulating hypertension and preparation method thereof | |
| CN101554471B (en) | Traditional Chinese medicine preparation for treating myocardial infarction | |
| CN104069463B (en) | A kind of Chinese drugs agentia for treating gynaecologic metrorrhagia | |
| CN105362556A (en) | Traditional Chinese medicine preparation for preventing and treating leukemia and preparing method thereof | |
| CN111671809A (en) | Medicament for treating cancer | |
| CN104491585A (en) | Paste with effects of expelling wind and removing dampness for rheumatic arthritis and preparation method of paste | |
| CN105106438A (en) | Traditional Chinese medicine composition for treating arrhythmia and preparation method thereof | |
| CN101375962B (en) | Formulation for activating blood and freeing collateral vessels and preparation method thereof | |
| CN103479777A (en) | Pure Chinese herbal composition for treating gosling plague and preparation method thereof | |
| CN105412834A (en) | Application of traditional Chinese medicine composition in preparing medicine for treating CAD (Coronary Artery Disease) | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN104888148A (en) | Medicament for chronic hepatitis B | |
| CN104784547A (en) | Traditional Chinese medicine composition having synergistic effect on radiotherapy and preparation method | |
| CN105497379A (en) | Chinese medicinal composition for treating coronary heart disease and preparation method thereof | |
| CN105168795A (en) | Oral drug for treating fatty liver and supplementing nutrition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |